Add-on Acquisition • Life Science

Veristat Acquires DDR

On November 11, 2021, Veristat acquired life science company DDR

Acquisition Context

This is Veristat’s 4th transaction in the Life Science sector.
This is Veristat’s 1st transaction in Spain.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	November 11, 2021
Target	DDR
Sector	Life Science
Buyer(s)	Veristat
Deal Type	Add-on Acquisition

Target Company

DDR

Barcelona, Spain

Drug Development and Regulation is an independent European consultancy with offices in Barcelona and Amsterdam, focused on providing appropriate scientific and regulatory expertise for the global development and registration of drugs and medical devices. The Company’s tailor-made solutions contribute to the success of clients’ development programs across quality, nonclinical, clinical, and regulatory functions. Drug Development and Regulation is based in Barcelona, Spain.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Veristat

Southborough, Massachusetts, United States

Category	Company
Founded	1994
Sector	Life Science

DESCRIPTION

Veristat is a scientifically minded global clinical research organization (CRO), enables biotech and pharmaceutical sponsors to solve unique and complex challenges associated with accelerating innovative therapies through clinical development to regulatory approval and post-approval. Veristat was founded in 1994 and is based in Southborough, Massachusetts.

Deal Context for Buyer	#
Overall	7 of 8
Sector: Life Science	4 of 4
Type: Add-on Acquisition	7 of 8
Country: Spain	1 of 1
Year: 2021	2 of 2

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2021-02-25	SQN Clinical Norfolk, United Kingdom SQN Clinical is a specialist in Biometrics CROs in Europe and is the preferred clinical development partner for many pharmaceutical, biotechnology, and animal healthcare companies in the UK, Europe, and the rest of the world. SQN Clinical supports the diverse needs of large and small organizations alike, consistently providing the assurance that advice and services offered will always meet development and regulatory needs. SQN Clinical is based in Norfolk, United Kingdom.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2021-02-25

SQN Clinical

Norfolk, United Kingdom

SQN Clinical is a specialist in Biometrics CROs in Europe and is the preferred clinical development partner for many pharmaceutical, biotechnology, and animal healthcare companies in the UK, Europe, and the rest of the world. SQN Clinical supports the diverse needs of large and small organizations alike, consistently providing the assurance that advice and services offered will always meet development and regulatory needs. SQN Clinical is based in Norfolk, United Kingdom.

Buy

FOLLOWING DEAL

DATE	TARGET	DEAL TYPE	VALUE
2023-10-19	Instat Clinical Research Chatham, New Jersey, United States Instat Clinical Research provides comprehensive statistical, data management and medical writing services for all phases of clinical development. Instat Clinical Research was founded in 2003 and is based in Chatham, New Jersey.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2023-10-19

Instat Clinical Research

Chatham, New Jersey, United States

Instat Clinical Research provides comprehensive statistical, data management and medical writing services for all phases of clinical development. Instat Clinical Research was founded in 2003 and is based in Chatham, New Jersey.

Buy

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Spain M&A - 2021 M&A